Literature DB >> 17122442

C-Peptide in insulin resistance and vascular complications: teaching an old dog new tricks.

Dennis Bruemmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17122442      PMCID： PMC1829170          DOI： 10.1161/01.RES.0000251785.83860.3b

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  25 in total

Review 1.  Impact of insulin resistance on neointimal tissue proliferation after coronary stent implantation. Intravascular ultrasound studies.

Authors:  Tsutomu Takagi; Takashi Akasaka; Atsushi Yamamuro; Yasuhiro Honda; Takeshi Hozumi; Shigefumi Morioka; Kiyoshi Yoshida
Journal:  J Diabetes Complications       Date:  2002 Jan-Feb       Impact factor: 2.852

Review 2.  Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies.

Authors:  Victor J Dzau; Ruediger C Braun-Dullaeus; Daniel G Sedding
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

3.  Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats.

Authors:  C Indolfi; D Torella; L Cavuto; A M Davalli; C Coppola; G Esposito; M V Carriero; A Rapacciuolo; E Di Lorenzo; E Stabile; C Perrino; A Chieffo; F Pardo; M Chiariello
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

4.  Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G-protein.

Authors:  T Kitamura; K Kimura; B D Jung; K Makondo; S Okamoto; X Cañas; N Sakane; T Yoshida; M Saito
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

5.  Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus.

Authors:  S H Park; S P Marso; Z Zhou; F Foroudi; E J Topol; A M Lincoff
Journal:  Circulation       Date:  2001-08-14       Impact factor: 29.690

Review 6.  Molecular mechanisms of insulin resistance that impact cardiovascular biology.

Authors:  Cecilia C Low Wang; Marc L Goalstone; Boris Draznin
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

7.  Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels.

Authors:  L A Suzuki; M Poot; R G Gerrity; K E Bornfeldt
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

Review 8.  Molecular effects of proinsulin C-peptide.

Authors:  Jan Johansson; Karin Ekberg; Jawed Shafqat; Mikael Henriksson; Alexander Chibalin; John Wahren; Hans Jörnvall
Journal:  Biochem Biophys Res Commun       Date:  2002-08-02       Impact factor: 3.575

9.  C-peptide induces chemotaxis of human CD4-positive cells: involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase.

Authors:  Daniel Walcher; Milos Aleksic; Verena Jerg; Vinzenz Hombach; Arthur Zieske; Satoki Homma; Jack Strong; Nikolaus Marx
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

10.  C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro.

Authors:  Nikolaus Marx; Daniel Walcher; Claudia Raichle; Milos Aleksic; Helga Bach; Miriam Grüb; Vinzenz Hombach; Peter Libby; Arthur Zieske; Satoki Homma; Jack Strong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-05       Impact factor: 8.311
View more
  6 in total

1.  The glucose-induced synthesis of insulin in liver.

Authors:  Rajeshwary Ghosh; Soumendra K Karmohapatra; Gorachand Bhattacharya; A Kumar Sinha
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

2.  Impact of Insulin Resistance on Neointimal Tissue Proliferation after 2nd-Generation Drug-Eluting Stent Implantation.

Authors:  Takaaki Komatsu; Isao Yaguchi; Sachiko Komatsu; Shiro Nakahara; Sayuki Kobayashi; Yoshihiko Sakai; Isao Taguchi
Journal:  Tex Heart Inst J       Date:  2015-08-01

3.  Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients.

Authors:  Sung-Tae Kim; Byung-Joon Kim; Dong-Mee Lim; In-Geol Song; Jang-Han Jung; Kang-Woo Lee; Keun-Young Park; Youn-Zoo Cho; Dae-Ho Lee; Gwan-Pyo Koh
Journal:  Diabetes Metab J       Date:  2011-02-28       Impact factor: 5.376

Review 4.  p38MAPK plays a pivotal role in the development of acute respiratory distress syndrome.

Authors:  Ying Feng; Zhicheng Fang; Boyi Liu; Xiang Zheng
Journal:  Clinics (Sao Paulo)       Date:  2019-08-12       Impact factor: 2.365

5.  Lack of associations between betatrophin/ANGPTL8 level and C-peptide in type 2 diabetic subjects.

Authors:  Mohamed Abu-Farha; Jehad Abubaker; Fiona Noronha; Irina Al-Khairi; Preethi Cherian; Monira Alarouj; Abdullah Bennakhi; Naser Elkum
Journal:  Cardiovasc Diabetol       Date:  2015-08-20       Impact factor: 9.951

6.  Comprehensive biomarker testing of glycemia, insulin resistance, and beta cell function has greater sensitivity to detect diabetes risk than fasting glucose and HbA1c and is associated with improved glycemic control in clinical practice.

Authors:  Stephen A Varvel; Szilard Voros; Dawn L Thiselton; James V Pottala; Tara Dall; G Russell Warnick; Joseph P McConnell; Leila Ghaedi; Maciek Sasinowski; Timothy Graham
Journal:  J Cardiovasc Transl Res       Date:  2014-07-29       Impact factor: 4.132
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.